title: [The interest and prospects of Daflon treatment in obstetrical and gynaecological practice].
authors.affiliation: Clinique Gynécologique et Obstétricale II, Hospices Civils, B. P. 426 R 5, 67005 Strasbourg, France.
authors.forename: P
authors.initials: P
authors.lastname: Muller
authors.forename: F
authors.initials: F
authors.lastname: Wolff
authors.forename: R A
authors.initials: RA
authors.lastname: Schick
authors.forename: R
authors.initials: R
authors.lastname: Szwarcberg
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004145:Diosmin / Q000627:therapeutic use*; D005260:Female; D006484:Hemorrhoids / Q000188:drug therapy; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects; D008595:Menorrhagia / Q000188:drug therapy; D008599:Menstruation Disturbances / Q000188:drug therapy*; D008796:Metrorrhagia / Q000188:drug therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D014592:Uterine Hemorrhage / Q000517:prevention & control; D014648:Varicose Veins / Q000188:drug therapy; D014689:Venous Insufficiency / Q000188:drug therapy
chemical_list: D002317:Cardiovascular Agents; D004145:Diosmin